Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2025
Two roads diverged in multiple sclerosis: When is switching therapy effective?Anthony T Reder
Neurology|October 6, 2010
MxA: a biomarker for predicting multiple sclerosis disease activityAnthony T Reder
The Journal of Clinical Investigation|April 28, 2023
Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse modelsAnthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Thoracic flexion provokes circumferential dysesthesia: A symptom of thoracic cord lesions in MSAnthony T Reder
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanismsAnthony T Reder, Xuan Feng
Neurology|March 29, 2019
Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoringJoep Killestein, Anthony T Reder
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drugAdil Javed, Anthony T Reder
Frontiers in Immunology|September 25, 2013
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body EcologyAnthony T Reder, Xuan Feng
Pharmacology & Therapeutics|October 19, 2005
Therapeutic role of beta-interferons in multiple sclerosisAdil Javed, Anthony T Reder
Neurology|June 9, 2004
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosisAnthony T Reder, Joel J Oger
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2025
Two roads diverged in multiple sclerosis: When is switching therapy effective?Anthony T Reder
Neurology|October 6, 2010
MxA: a biomarker for predicting multiple sclerosis disease activityAnthony T Reder
The Journal of Clinical Investigation|April 28, 2023
Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse modelsAnthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Thoracic flexion provokes circumferential dysesthesia: A symptom of thoracic cord lesions in MSAnthony T Reder
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanismsAnthony T Reder, Xuan Feng
Neurology|March 29, 2019
Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoringJoep Killestein, Anthony T Reder
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drugAdil Javed, Anthony T Reder
Frontiers in Immunology|September 25, 2013
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body EcologyAnthony T Reder, Xuan Feng
Pharmacology & Therapeutics|October 19, 2005
Therapeutic role of beta-interferons in multiple sclerosisAdil Javed, Anthony T Reder
Neurology|June 9, 2004
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosisAnthony T Reder, Joel J Oger
Pageof 9